MedPath

Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal Cancer

Not Applicable
Conditions
Colorectal Cancer
Interventions
Behavioral: dual-task walking
Registration Number
NCT04490733
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The aims of this three-year study are to explore cognitive function under different stages of colorectal cancer (CRC) and its related factors; and understand its disturbance and coping process caused by cancer-induced cognitive impairment (CICI) from patient perspective; and further to test effect of dual-task walking on improving cognitive function in CRC patients.

Detailed Description

Developing risk prediction model of mild cognitive impairment in patients with colorectal cancer from active treatment to survivor by exploring the effect of surgery and chemotherapy on CICI, and to identify high risk population; and testing the effect of dual-task walking on improving cognitive function (memory, executive function and attention) in CRC patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
355
Inclusion Criteria
  • Patients with newly diagnosed stage I to III colorectal cancer and Montreal Cognitive Assessment (MoCA) < 24.
Read More
Exclusion Criteria
  • Patients with cancer other than colorectal cancer or have cancer recurrence.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupdual-task walkingParticipants in the experimental group will receive 3 times interventions during 10th to 12th course of chemotherapy and 12 weekly phone-call to assess effect and barriers of dual-task walking.
Primary Outcome Measures
NameTimeMethod
Neuropsychological battery testChange from baseline cognitive function at 12 months

Five neuropsychological battery tests will be used to assess cognitive function of memory

Self-report QuestionnaireChange from baseline cognitive function at 12 months

The questionnaire includes 37 items to assess perceived cognitive function

Secondary Outcome Measures
NameTimeMethod
Self-report QuestionnaireChange from baseline symptom at 12 months

The questionnaire includes 24 items to assess symptom severity

Trial Locations

Locations (1)

National Taiwan University

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath